HLA-DRB1 and myeloid sarcoma: Increased risk for MS was confirmed for the minor alleles of EVI5, HLA-DRB and CLEC16A, and for the major alleles of CD58 and IL7R. For IL2RA the association was not statistically significant (OR 1.14, 95% CI 0.95–1.38).